Sol-Gel Technologies (SLGL) Total Current Liabilities (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Total Current Liabilities came in at $6.3 million in Q1 2026, up 38.05% year-on-year from $4.6 million in Q1 2025, and up 2.3% on a QoQ basis from $6.2 million in Q4 2025.

Sol-Gel Technologies (SLGL) Total Current Liabilities (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Total Current Liabilities data on file, last reported at $6.3 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 38.05% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 38.05% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 16.76% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $6.3 million, up from $6.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for SLGL reached as high as $6.5 million in Q3 2024 and fell as low as $2.6 million in Q3 2022.
  • Historically, Total Current Liabilities has averaged $4.8 million across 5 years, with a median of $5.0 million in 2025.
  • Across the five-year window, Total Current Liabilities tumbled 72.74% in 2022 and jumped 75.72% in 2023, its largest moves.
  • Year by year, Total Current Liabilities stood at $3.3 million in 2022, then jumped by 35.84% to $4.5 million in 2023, then climbed by 16.87% to $5.3 million in 2024, then rose by 16.76% to $6.2 million in 2025, then climbed by 2.3% to $6.3 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $6.3 million in Q1 2026, $6.2 million in Q4 2025, and $6.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - 6.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.31 Mn
Dec 31, 2025 6.17 Mn
Sep 30, 2025 6.15 Mn
Jun 30, 2025 4.96 Mn
Mar 31, 2025 4.57 Mn
Dec 31, 2024 5.29 Mn
Sep 30, 2024 6.53 Mn
Jun 30, 2024 5.20 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 4.52 Mn
Sep 30, 2023 4.51 Mn
Jun 30, 2023 5.67 Mn
Mar 31, 2023 3.92 Mn
Dec 31, 2022 3.33 Mn
Sep 30, 2022 2.60 Mn
Jun 30, 2022 3.23 Mn
Mar 31, 2022 4.21 Mn
Dec 31, 2021 11.69 Mn
Sep 30, 2021 9.53 Mn
Jun 30, 2021 5.16 Mn